RedHill Biopharma (RDHL) Competitors

RedHill Biopharma (NASDAQ:RDHL) and Cocrystal Pharma (NASDAQ:COCP) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability, community ranking and media sentiment.

Does the MarketBeat Community prefer RDHL or COCP?

RedHill Biopharma received 406 more outperform votes than Cocrystal Pharma when rated by MarketBeat users. However, 75.00% of users gave Cocrystal Pharma an outperform vote while only 69.32% of users gave RedHill Biopharma an outperform vote.

Company	Underperform	Outperform
RedHill Biopharma	Outperform Votes 427 69.32%	Underperform Votes 189 30.68%
Cocrystal Pharma	Outperform Votes 21 75.00%	Underperform Votes 7 25.00%

Which has stronger valuation and earnings, RDHL or COCP?

RedHill Biopharma has higher revenue and earnings than Cocrystal Pharma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RedHill Biopharma	$6.53M	2.06	$23.92M	N/A	N/A
Cocrystal Pharma	N/A	N/A	-$17.98M	-$1.99	-0.75

Do insiders & institutionals believe in RDHL or COCP?

7.2% of RedHill Biopharma shares are owned by institutional investors. Comparatively, 6.7% of Cocrystal Pharma shares are owned by institutional investors. 6.8% of RedHill Biopharma shares are owned by insiders. Comparatively, 25.1% of Cocrystal Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Is RDHL or COCP more profitable?

RedHill Biopharma's return on equity of 0.00% beat Cocrystal Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RedHill Biopharma	N/A	N/A	N/A
Cocrystal Pharma	N/A	-59.62%	-54.62%

Which has more risk & volatility, RDHL or COCP?

RedHill Biopharma has a beta of 3.45, meaning that its stock price is 245% more volatile than the S&P 500. Comparatively, Cocrystal Pharma has a beta of 1.34, meaning that its stock price is 34% more volatile than the S&P 500.

Does the media refer more to RDHL or COCP?

In the previous week, RedHill Biopharma had 1 more articles in the media than Cocrystal Pharma. MarketBeat recorded 1 mentions for RedHill Biopharma and 0 mentions for Cocrystal Pharma. RedHill Biopharma's average media sentiment score of 0.00 equaled Cocrystal Pharma'saverage media sentiment score.

Company	Overall Sentiment
RedHill Biopharma	Neutral
Cocrystal Pharma	Neutral

Do analysts rate RDHL or COCP?

Cocrystal Pharma has a consensus target price of $10.00, indicating a potential upside of 566.67%. Given Cocrystal Pharma's higher probable upside, analysts clearly believe Cocrystal Pharma is more favorable than RedHill Biopharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RedHill Biopharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Cocrystal Pharma	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

RedHill Biopharma beats Cocrystal Pharma on 8 of the 12 factors compared between the two stocks.